Nifty
:
11930.35
Sensex
:
40685.50
33.90 (0.28%)
127.01 (0.31%)
Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs

Rating :
58/99  (View)

BSE: 524654 | NSE: Not Listed

NSE BSE
73.00
1.90 (2.67%)
23-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  77.90
  •  77.90
  •  72.35
  •  71.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3701
  •  2.70
  •  99.90
  •  32.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 45.50
  • 15.32
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 50.83
  • 0.82%
  • 0.78

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.17%
  • 0.00%
  • 30.80%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 17.03%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.07
  • -0.16
  • 3.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.82
  • -10.94
  • -0.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -15.20
  • -27.66
  • -8.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 14.84
  • 17.28

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.13
  • 0.32
  • 0.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.40
  • 3.35
  • 6.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
16
14
14%
16
16
-1%
16
15
7%
16
14
8%
Expenses
14
13
13%
14
15
-5%
15
14
5%
15
14
6%
EBITDA
2
1
29%
2
1
47%
2
1
28%
1
1
45%
EBIDTM
10%
9%
14%
6%
10%
8%
6%
4%
Other Income
0
0
26%
0
0
133%
0
0
-31%
0
1
-69%
Interest
0
0
0%
0
0
36%
0
0
108%
0
0
78%
Depreciation
1
1
14%
1
0
288%
1
1
72%
1
1
-31%
PBT
3
0
553%
0
1
-67%
0
0
8%
0
0
-10%
Tax
0
0
360%
0
0
-
0
0
138%
0
0
71%
PAT
2
0
589%
0
1
-88%
0
0
-25%
0
0
-35%
PATM
16%
3%
7%
6%
1%
2%
1%
2%
EPS
4.00
0.58
590%
0.18
1.47
-88%
0.39
0.52
-25%
0.24
0.37
-35%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Net Sales
64
62
60
55
Net Sales Growth
7%
3%
9%
 
Cost Of Goods Sold
4,667
28
26
24
Gross Profit
-4,603
34
33
31
GP Margin
-7,245%
54%
56%
57%
Total Expenditure
58
56
55
49
Power & Fuel Cost
-
8
9
7
% Of Sales
-
13%
15%
12%
Employee Cost
-
6
6
5
% Of Sales
-
10%
9%
10%
Manufacturing Exp.
-
6
6
5
% Of Sales
-
9%
10%
9%
General & Admin Exp.
-
4
4
3
% Of Sales
-
6%
6%
6%
Selling & Distn. Exp.
-
4
4
5
% Of Sales
-
7%
7%
10%
Miscellaneous Exp.
-
0
0
0
% Of Sales
-
1%
0%
1%
EBITDA
6
5
5
6
EBITDA Margin
9%
9%
8%
10%
Other Income
1
1
1
1
Interest
1
1
1
0
Depreciation
4
4
3
4
PBT
4
1
2
2
Tax
1
1
0
1
Tax Rate
23%
37%
7%
34%
PAT
3
1
2
1
PAT before Minority Interest
3
1
2
1
Minority Interest
0
0
0
0
PAT Margin
5%
1%
3%
2%
PAT Growth
64%
-55%
73%
 
EPS
4.81
1.39
3.10
1.79

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
56
55
54
Share Capital
6
6
6
Total Reserves
49
49
48
Non-Current Liabilities
1
1
2
Secured Loans
0
0
0
Unsecured Loans
0
0
0
Long Term Provisions
0
0
0
Current Liabilities
18
16
15
Trade Payables
7
8
12
Other Current Liabilities
5
3
2
Short Term Borrowings
6
5
0
Short Term Provisions
0
0
1
Total Liabilities
75
73
71
Net Block
24
24
22
Gross Block
70
66
61
Accumulated Depreciation
46
42
40
Non Current Assets
37
35
29
Capital Work in Progress
2
2
1
Non Current Investment
6
5
5
Long Term Loans & Adv.
5
2
0
Other Non Current Assets
1
1
1
Current Assets
38
38
42
Current Investments
0
0
0
Inventories
5
4
8
Sundry Debtors
30
32
31
Cash & Bank
1
0
1
Other Current Assets
1
0
0
Short Term Loans & Adv.
1
1
2
Net Current Assets
20
22
27
Total Assets
75
73
71

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
7
2
5
PBT
1
2
2
Adjustment
5
4
5
Changes in Working Capital
2
-3
-1
Cash after chg. in Working capital
8
3
5
Interest Paid
0
0
0
Tax Paid
-1
-1
0
Other Direct Exp. Paid
0
0
0
Extra & Other Items
0
0
0
Cash From Investing Activity
-6
-7
-1
Net Fixed Assets
-3
-6
Net Investments
0
0
Others
-2
-1
Cash from Financing Activity
-1
4
-4
Net Cash Inflow / Outflow
0
-1
0
Opening Cash & Equivalents
0
1
0
Closing Cash & Equivalent
0
0
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
89
89
87
ROA
1%
3%
2%
ROE
2%
4%
2%
ROCE
4%
5%
4%
Fixed Asset Turnover
0.91
0.94
0.89
Receivable days
185
194
208
Inventory Days
28
37
51
Payable days
48
70
83
Cash Conversion Cycle
165
161
176
Total Debt/Equity
0.11
0.10
0.00
Interest Cover
3
5
6

Annual Reports:

Financial Year 2019
Financial Year 2018
Financial Year 2017
Financial Year 2016
Financial Year 2015
Financial Year 2014
Financial Year 2013
Financial Year 2012

News Update


  • Natural Capsules incorporates WOS company
    26th Aug 2020, 09:52 AM

    The company has incorporated a WOS company namely ‘Natural Biogenex’ on August 23, 2020

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.